)
Andrew Geall
Co-Founder and Chief Development Officer,
Replicate Bioscience
Dr. Andy Geall is the Chief Development Officer and cofounder of Replicate Bioscience, a San Diego (California) based Biotech. The company has developed a diverse proprietary repertoire of virally derived self-replicating RNA vectors, which are being used to tackle a range of disease indications in oncology, infectious disease, autoimmune and inflammatory disorders. Dr. Geall has over 20 years of professional experience in the development of drug delivery systems and is a pioneer in the fields of mRNA vaccines and nucleic acid delivery. He is an inventor on 41 patent families, with 505 applications and 203 issued patents in multiple jurisdictions.